BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND HLA-A, P01892, 3105, ENSG00000206503, P16188, P30447, P13746, P04439 AND Prognosis
15 results:

  • 1. Development of a Unique T Cell Receptor Gene-Transferred Tax-Redirected T Cell Immunotherapy for Adult T Cell Leukemia.
    Kawamura K; Tanaka Y; Nakasone H; Ishihara Y; Kako S; Kobayashi S; Tanaka Y; Ohmori T; Uchimaru K; Okamoto S; Mineno J; Shiku H; Nishimura S; Kanda Y
    Biol Blood Marrow Transplant; 2020 Aug; 26(8):1377-1385. PubMed ID: 32311478
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling.
    Watatani Y; Sato Y; Miyoshi H; Sakamoto K; Nishida K; Gion Y; Nagata Y; Shiraishi Y; Chiba K; Tanaka H; Zhao L; Ochi Y; Takeuchi Y; Takeda J; Ueno H; Kogure Y; Shiozawa Y; Kakiuchi N; Yoshizato T; Nakagawa MM; Nanya Y; Yoshida K; Makishima H; Sanada M; Sakata-Yanagimoto M; Chiba S; Matsuoka R; Noguchi M; Hiramoto N; Ishikawa T; Kitagawa J; Nakamura N; Tsurumi H; Miyazaki T; Kito Y; Miyano S; Shimoda K; Takeuchi K; Ohshima K; Yoshino T; Ogawa S; Kataoka K
    Leukemia; 2019 Dec; 33(12):2867-2883. PubMed ID: 31092896
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Pediatric mycosis fungoides: a study of the human leukocyte antigen system among Israeli Jewish patients.
    Reiter O; Ben Amitai D; Amitay-Laish I; Israeli M; Pavlovsky L; Hodak E
    Arch Dermatol Res; 2017 Dec; 309(10):851-856. PubMed ID: 28948342
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Genetic alterations in adult T-cell leukemia/lymphoma.
    Kogure Y; Kataoka K
    Cancer Sci; 2017 Sep; 108(9):1719-1725. PubMed ID: 28627735
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Immunogenetic factors in mycosis fungoides: can the HLA system influence the susceptibility and prognosis of the disease? Long-term follow-up study of 46 patients.
    Brazzelli V; Rivetti N; Badulli C; Carugno A; Grasso V; De Silvestri A; Martinetti M; Borroni G
    J Eur Acad Dermatol Venereol; 2014 Dec; 28(12):1732-7. PubMed ID: 24533560
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Standard therapies versus novel therapies in Hodgkin lymphoma.
    Gallamini A; Di Raimondo F; La Nasa G; Romano A; Borra A; Greco M
    Immunol Lett; 2013; 155(1-2):56-9. PubMed ID: 24140162
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. HLA specificities are related to development and prognosis of diffuse large B-cell lymphoma.
    Alcoceba M; Sebastián E; Marín L; Balanzategui A; Sarasquete ME; Chillón MC; Jiménez C; Puig N; Corral R; Pardal E; Grande C; Bello JL; Albo C; de la Cruz F; Panizo C; Martín A; González-Barca E; Caballero MD; San Miguel JF; García-Sanz R; González M
    Blood; 2013 Aug; 122(8):1448-54. PubMed ID: 23843497
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Development of a novel redirected T-cell-based adoptive immunotherapy targeting human telomerase reverse transcriptase for adult T-cell leukemia.
    Miyazaki Y; Fujiwara H; Asai H; Ochi F; Ochi T; Azuma T; Ishida T; Okamoto S; Mineno J; Kuzushima K; Shiku H; Yasukawa M
    Blood; 2013 Jun; 121(24):4894-901. PubMed ID: 23641014
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [The impact of HLA high resolution typing mismatching of donor-recipient pairs on outcome of unrelated donor hematopoietic stem cell transplantation].
    He J; Xu C; Wu XJ; Bao XJ; Qiu QC; Yuan XN; Li Y; Shen HJ; Wu DP; Hong JL; Liu JH; DU HY; Zhang L; DU D; Lu J; Liu J
    Zhonghua Xue Ye Xue Za Zhi; 2012 May; 33(5):353-7. PubMed ID: 22781790
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Human leukocyte antigen class I and II alleles and overall survival in diffuse large B-cell lymphoma and follicular lymphoma.
    Lu Y; Abdou AM; Cerhan JR; Morton LM; Severson RK; Davis S; Cozen W; Rothman N; Bernstein L; Chanock S; Hartge P; Wang SS
    ScientificWorldJournal; 2011; 11():2062-70. PubMed ID: 22125456
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Cyclin D1 as a universally expressed mantle cell lymphoma-associated tumor antigen for immunotherapy.
    Wang M; Sun L; Qian J; Han X; Zhang L; Lin P; Cai Z; Yi Q
    Leukemia; 2009 Jul; 23(7):1320-8. PubMed ID: 19225534
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. B and CTL responses to the ALK protein in patients with ALK-positive ALCL.
    Ait-Tahar K; Cerundolo V; Banham AH; Hatton C; Blanchard T; Kusec R; Becker M; Smith GL; Pulford K
    Int J Cancer; 2006 Feb; 118(3):688-95. PubMed ID: 16114011
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Unrelated donor bone marrow transplantation for children with acute leukemia.
    Davies SM; Wagner JE; Shu XO; Blazar BR; Katsanis E; Orchard PJ; Kersey JH; Dusenbery KE; Weisdorf DJ; McGlave PB; Ramsay NK
    J Clin Oncol; 1997 Feb; 15(2):557-65. PubMed ID: 9053477
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Major histocompatibility complex class I and class II antigen expression in diffuse large cell and large cell immunoblastic lymphomas. Absence of a correlation between antigen expression and clinical outcome.
    Medeiros LJ; Gelb AB; Wolfson K; Doggett R; McGregor B; Cox RS; Horning SJ; Warnke RA
    Am J Pathol; 1993 Oct; 143(4):1086-97. PubMed ID: 8214004
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Defective expression of MHC class I antigens is frequent in B-cell lymphomas of high-grade malignancy.
    Möller P; Herrmann B; Moldenhauer G; Momburg F
    Int J Cancer; 1987 Jul; 40(1):32-9. PubMed ID: 3298077
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.